Article: BRAZIL BREAKS HIV-DRUG PATENT AFTER FAILED NEGOTIATIONS WITH PHARMACEUTICAL GIANT MERCK.

Brazilian President Luiz Inacio Lula da Silva has said his country will import a cheaper generic version of a patented drug to treat AIDS after US pharmaceutical giant Merck refused to give Brazil the price breaks it was calling for. Brazil had previously stated that it would break patents on AIDS drugs if pharmaceutical companies failed to offer adequate price reductions (see NotiSur, 2003-09-05). The decision to make a compulsory license for the drug was the first patent bypass Brazil has done, leading US corporate leaders and the government to suggest that they would threaten investment into Brazil and into pharmaceutical research and development, accusations Brazil ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!